• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管化复合组织同种异体移植作为同种异体移植排斥的机制模型——一项实验研究。

Vascularized composite allotransplants as a mechanistic model for allograft rejection - an experimental study.

机构信息

Department of Surgery, Duke University Medical Center, Durham, NC, USA.

Department of Pathology, Duke University, Durham, NC, USA.

出版信息

Transpl Int. 2021 Mar;34(3):572-584. doi: 10.1111/tri.13820. Epub 2021 Feb 9.

DOI:10.1111/tri.13820
PMID:33453073
Abstract

Vascularized composite allotransplants (VCAs) seem to have several unique features of clinical and experimental importance, including uniquely definable lymphatic drainage that can be easily accessed at the level of ipsilateral regional node beds. Thus, VCA offers a unique opportunity to assess the relative contribution of peripheral and secondary lymphoid tissue to the process of rejection. We transplanted hind limb grafts from C3H donors to six different groups of C57BL/6 recipients: Spleen Map3k14 ; Spleen Map3k14 ; Spleen Node Map3k14 ; and Spleen Node Map3k14 . As positive controls, we used Map3k14 with or without spleen. Map3k14 mice demonstrated an average graft survival of 9.6 and 9.2 days for Spleen and Spleen Map3k14 , respectively. Rejection in the Map3k14 group was considerably delayed (28.4 days, P = 0.002) in all recipients. The Spleen Map3k14 mice rejected their hind limb allografts in an even more delayed fashion compared to Spleen Map3k14 (54.4 days, P = 0.02). Histological analysis of skin showed that acute rejection in both Map3k14 mice groups was graded as Banff III or Banff IV. In the Map3k14 groups, rejection was graded as Banff III. We demonstrated that in the absence of lymph nodes, grafts reject in a delayed fashion. Also, splenectomy in alymphoplastic mice further extends graft survival, but does not eliminate rejection all together.

摘要

血管化复合组织同种异体移植(VCAs)似乎具有一些独特的临床和实验特征,包括独特的可定义的淋巴引流,可以在同侧区域淋巴结床水平上轻松触及。因此,VCA 为评估外周和次级淋巴组织对排斥反应过程的相对贡献提供了独特的机会。我们将 C3H 供体的后肢移植物移植到六组不同的 C57BL/6 受体中:脾 Map3k14 ;脾 Map3k14 ;脾节点 Map3k14 ;和脾节点 Map3k14 。作为阳性对照,我们使用了有或没有脾脏的 Map3k14。Map3k14 小鼠的脾脏和脾 Map3k14 分别平均移植物存活 9.6 和 9.2 天。在所有受体中,Map3k14 组的排斥反应明显延迟(28.4 天,P=0.002)。与脾 Map3k14 相比,脾 Map3k14 小鼠的后肢同种异体移植物排斥更加延迟(54.4 天,P=0.02)。皮肤的组织学分析表明,两组 Map3k14 小鼠的急性排斥反应均被评为 Banff III 或 Banff IV。在 Map3k14 组中,排斥反应被评为 Banff III。我们证明,在没有淋巴结的情况下,移植物会延迟排斥。此外,在无淋巴组织的小鼠中进行脾切除术可进一步延长移植物的存活时间,但并不能完全消除排斥反应。

相似文献

1
Vascularized composite allotransplants as a mechanistic model for allograft rejection - an experimental study.血管化复合组织同种异体移植作为同种异体移植排斥的机制模型——一项实验研究。
Transpl Int. 2021 Mar;34(3):572-584. doi: 10.1111/tri.13820. Epub 2021 Feb 9.
2
Depletion of donor dendritic cells ameliorates immunogenicity of both skin and hind limb transplants.捐献者树突状细胞耗竭可改善皮肤和后肢移植物的免疫原性。
Front Immunol. 2024 May 10;15:1395945. doi: 10.3389/fimmu.2024.1395945. eCollection 2024.
3
Vascularized bone grafts within composite tissue allotransplants can autocreate tolerance through mixed chimerism with partial myeloablative conditioning: an experimental study in rats.复合组织同种异体移植中的带血管骨移植物可通过部分骨髓清除条件下的嵌合混合产生自身耐受:大鼠实验研究。
Plast Reconstr Surg. 2010 Apr;125(4):1095-1103. doi: 10.1097/PRS.0b013e3181d0ab80.
4
The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.丝裂霉素诱导的血细胞与环孢素A的短期治疗相结合可延长血管化复合异体移植中同种异体移植物的存活时间。
Langenbecks Arch Surg. 2018 Feb;403(1):83-92. doi: 10.1007/s00423-017-1616-3. Epub 2017 Aug 19.
5
A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.一种新型大鼠全层半腹壁/后肢骨肌皮联合皮瓣:同种异体移植物质量和带血管骨髓含量对血管化复合组织异体移植存活的影响。
Transpl Int. 2014 Sep;27(9):977-86. doi: 10.1111/tri.12364. Epub 2014 Jul 29.
6
Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.通过同基因造血干细胞移植实现血管化复合组织同种异体移植中的脱敏和预防抗体介导的排斥反应。
Transplantation. 2018 Apr;102(4):593-600. doi: 10.1097/TP.0000000000002070.
7
Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts.人手部、非人灵长类动物及大鼠血管化复合异体移植皮肤中的淋巴新生。
Transpl Int. 2014 Sep;27(9):966-76. doi: 10.1111/tri.12358. Epub 2014 Jun 24.
8
Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study.移植物植入、酶响应、他克莫司洗脱水凝胶使原位猪肢体血管化复合同种异体移植物长期存活:概念验证研究。
PLoS One. 2019 Jan 24;14(1):e0210914. doi: 10.1371/journal.pone.0210914. eCollection 2019.
9
Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.移植体内注射他克莫司可促进血管化复合组织异体移植的存活。
J Surg Res. 2017 Oct;218:49-57. doi: 10.1016/j.jss.2017.05.046. Epub 2017 Jun 10.
10
Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.血管化复合组织异体移植:预防急性排斥反应和慢性移植物退变的现行标准及新方法
Transpl Int. 2016 Jun;29(6):655-62. doi: 10.1111/tri.12652. Epub 2015 Sep 14.

引用本文的文献

1
Cellular activation pathways and interaction networks in vascularized composite allotransplantation.血管化复合组织同种异体移植中的细胞激活途径和相互作用网络。
Front Immunol. 2023 May 17;14:1179355. doi: 10.3389/fimmu.2023.1179355. eCollection 2023.
2
Sensitization and Desensitization in Vascularized Composite Allotransplantation.血管化复合组织移植中的致敏与脱敏。
Front Immunol. 2021 Aug 11;12:682180. doi: 10.3389/fimmu.2021.682180. eCollection 2021.